This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic cytokine with multiple functions. It is produced by T cells, B cells, macrophages, mast cells, endothelial cells, and fibroblasts. Dranoff et al¹ were the first to show the antitumor reactivity in B16 mice following active immunization with B16 melanoma cells transfected with the GM-CSF gene. Granulocyte-macrophage colony-stimulating factor has also been reported to accelerate pressure ulcer healing, and regression of metastatic carcinoma in skin appendages.^2-3 Recently, Leong et al⁴ demonstrated that autologous tumor vaccine with local recombinant human GM-CSF (rhGM-CSF) injections resulted in tumor regression in patients with stage IV melanoma.

Report of a Case

An 83-year-old white woman presented with a medical history of squamous cell carcinoma, solar keratosis, and melanoma in situ of the right upper eyelid. When the patient was first seen at the University of California, San Francisco, Melanoma Center on July 28, 1997, a 2-cm brown to black, irregular-bordered plaque of the . . . [Full Text of this Article]

Comment


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Complete Remission of Brain Metastases in Three Patients with Stage IV Melanoma Treated with BOLD and G-CSF
Bottoni et al.
Jpn J Clin Oncol 2005;35:507-513.
ABSTRACT | FULL TEXT  

Phase I Study of the Intratumoral Administration of Recombinant Canarypox Viruses Expressing B7.1 and Interleukin 12 in Patients with Metastatic Melanoma
Triozzi et al.
Clin. Cancer Res. 2005;11:4168-4175.
ABSTRACT | FULL TEXT  

Quantitative Analysis of Melanoma-Induced Cytokine-Mediated Immunosuppression in Melanoma Sentinel Nodes
Lee et al.
Clin. Cancer Res. 2005;11:107-112.
ABSTRACT | FULL TEXT  

Granulocyte-Macrophage Colony-Stimulating Factor: Another Cytokine With Adjuvant Therapeutic Benefit in Melanoma?
Lawson and Kirkwood
JCO 2000;18:1603-1605.
FULL TEXT